Cantor Fitzgerald raises Coinbase stock price target on product outlook

The market is no longer pricing COIN like a pure beta proxy; it is starting to value it as a derivatives-on-crypto liquidity platform where product mix and regulatory optionality matter more than spot prices. That shift matters because earnings pressure from weak trading volumes is a lagging indicator, while the next leg of re-rating will come from whether new offerings can monetize engagement without needing a sustained crypto rally. In other words, the stock can hold up even if headline volumes stay soft, but only if management proves that non-transaction revenue can offset cycle weakness.

The underappreciated second-order effect is that a cleaner U.S. regulatory backdrop would not just help Coinbase — it would widen the gap versus offshore venues that rely more heavily on price-sensitive trading flow. If the company can convert current interest in prediction markets into sticky user behavior, it adds a new monetization vector that is less tethered to BTC/ETH volatility and may improve valuation quality over the next 2-3 quarters. That said, the current move has already priced in a meaningful amount of good news, so a modest earnings miss or cautious guidance could compress multiples quickly because the name is being owned for a forward thesis, not for current fundamentals.

Consensus appears too focused on whether Q1 volumes were weak and not enough on what level of “acceptable stagnation” the market will tolerate if management can show product-led share gains. The risk is that COIN becomes a crowded long on the belief that regulation and new products will solve cyclical weakness; if those catalysts slip, the downside is amplified because the stock has recently re-rated ahead of proof. The most interesting asymmetry is that the first sign of durable non-trading monetization could trigger a larger rerating than the market expects, but absent that, the stock likely trades as a high-beta multiple compression story over the next 1-2 months.